Search hospitals

>

Virginia

>

Fairfax

Fairfax Northern Virginia Hematology OnCology, PC

Claim this profile

Fairfax, Virginia 22031

Global Leader in Lung Cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Pancreatic Cancer

Conducts research for Solid Tumors

Conducts research for Small Cell Lung Cancer

21 reported clinical trials

2 medical researchers

Photo of Fairfax Northern Virginia Hematology OnCology, PC in FairfaxPhoto of Fairfax Northern Virginia Hematology OnCology, PC in FairfaxPhoto of Fairfax Northern Virginia Hematology OnCology, PC in Fairfax

Summary

Fairfax Northern Virginia Hematology OnCology, PC is a medical facility located in Fairfax, Virginia. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Solid Tumors, Small Cell Lung Cancer and other specialties. Fairfax Northern Virginia Hematology OnCology, PC is involved with conducting 21 clinical trials across 24 conditions. There are 2 research doctors associated with this hospital, such as Alexander Spira, MD and Mitul Gandhi.

Area of expertise

1

Lung Cancer

Global Leader

Fairfax Northern Virginia Hematology OnCology, PC has run 11 trials for Lung Cancer. Some of their research focus areas include:

KRAS positive
Stage IV
Stage I
2

Non-Small Cell Lung Cancer

Fairfax Northern Virginia Hematology OnCology, PC has run 6 trials for Non-Small Cell Lung Cancer.

Top PIs

Alexander Spira, MD

Virginia Cancer Specialists

4 years of reported clinical research

Expert in Lung Cancer
Expert in Solid Tumors
139 reported clinical trials
181 drugs studied

Mitul Gandhi

Virginia Cancer Specialists

3 years of reported clinical research

Studies B-Cell Lymphoma
Studies Acute Myelogenous Leukemia
18 reported clinical trials
32 drugs studied

Clinical Trials running at Fairfax Northern Virginia Hematology OnCology, PC

Follicular Lymphoma

Non-Hodgkin's Lymphoma

Image of trial facility.

Tazemetostat + Lenalidomide + Rituximab

for Follicular Lymphoma

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.

Recruiting

1 award

Phase 3

4 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Fairfax Northern Virginia Hematology OnCology, PC?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security